Insiders · Profile

Young James Emmett

Chief Financial Officer at TriSalus Life Sciences. Filing since 27 Jan 2025. CIK 0002050748

Company
Date
Role
Action
Shares
Amount
Of holding
5 Feb 2025
Chief Financial Officer
Bought
6,000
$33.90K
25.0%
27 Jan 2025
Chief Financial Officer
Bought
24,000
$129.60K
opened
2 decisions on file.